ASU Anti-Cancer Center experiments with immunosignatures of lung cancer

20 September 2016 Public Relations Department
Russian-American Anti-Cancer Center under Altai State University, Nadezhda Regional Cancer Center and Arizona State University (USA) have proceeded to realization of new stage in immunosignature testing.

In 2015 Anti-Cancer Center developed an immunosignature for breast cancer. Now the scientists are collecting blood samples of patients suffering from lung cancer.

“Specialists of Nadezhda Cancer Center ran a campaign “Say no to cancer!” and collected blood samples of both healthy people and those, who have lung cancer. These samples will be tested by ASU Russian-American Anti-Cancer Center in order to find out if this is possible to distinguish healthy people from oncology patients with immunosignature,” said executive director of ASU Russian-American Anti-Cancer Center, Candidate of Biology Andrey I. Shapoval.

In particular, in the course of the campaign more than 250 blood samples of Altai Krai citizens, who do not have cancer, were gathered for the purpose of forming healthy samples database, which will serve for research.

ASU Anti-Cancer Center also forms collection of blood samples infected with blood cancer. Over 60 examples of male and female oncology patients have already been gathered. They will be used on the first stage of testing.

“We are planning to conduct the comparative experiment in following two weeks. Then we will carry out mathematical analysis of acquired data and other necessary operations,” clarified Andrey I. Shapoval.

Immunosignature technology was invented by Professor Stephen Johnston and his colleagues at the Center of Innovative Medicine at Arizona State University (USA). Memorandum on Russian-American Anti-Cancer Center establishment was signed in June 2013 in Barnaul. The participants include the scientists of Arizona State University on American side and the scientists of Altai State University, Altai State Medical University, Nadezhda Regional Cancer Center and SB RAS Institute for Chemical Biology and Fundamental Medicine on the Russian side.
Printable version